Verrica Pharmaceuticals Inc.

NasdaqGM:VRCA Stock Report

Market Cap: US$89.7m

Verrica Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

Verrica Pharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.2%

Buyback Yield

Total Shareholder Yield-0.2%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%

Oct 03
The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 17
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For

Aug 16
With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For

Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Jul 21
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Jan 11
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation

Jun 28
Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation

We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely

Feb 05
We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely

Vectoring Back In On Verrica Pharmaceuticals

Aug 31

Verrica Pharmaceuticals reports insider buying

Jul 06

Verrica Pharmaceuticals stock slides on proposed share offering

Jun 29

Verrica Pharmaceuticals Should Receive Second CRL Today

May 24

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VRCA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VRCA's dividend payments have been increasing.


Dividend Yield vs Market

Verrica Pharmaceuticals Dividend Yield vs Market
How does VRCA dividend yield compare to the market?
SegmentDividend Yield
Company (VRCA)n/a
Market Bottom 25% (US)1.3%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (VRCA) (up to 3 years)n/a

Notable Dividend: Unable to evaluate VRCA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VRCA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate VRCA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VRCA has not reported any payouts.


Discover strong dividend paying companies